Labcorp EVP Bailey resigns; Caveney to lead Biopharma Lab Services

LABCORP HOLDINGS INC.

Megan D. Bailey resigns as EVP & President, Central Laboratories and International, effective Sept 4, 2026.
Brian J. Caveney, M.D. becomes EVP & President, Biopharma Laboratory Services and Chief Medical & Scientific Officer on Sept 1, 2026.
Caveney will oversee Early Development Research Laboratories and Central Laboratories businesses.
Caveney previously led Early Development Research Laboratories and served as Chief Medical and Scientific Officer.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.